Related Experiment Video

Updated: Jul 20, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K

Identifying Indications for Neoadjuvant Therapy in Cholangiocarcinoma

Hilary R Keller, Laura Fluke, Jared A Forrester

    Oncology (Williston Park, N.Y.)
    |April 25, 2024
    PubMed

    Abstract:

    The recent Hot Topics section focuses on survival rates for patients with cholangiocarcinoma.

    More Related Videos

    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
    09:11

    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

    Published on: May 24, 2024

    415
    Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
    04:50

    Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

    Published on: January 17, 2025

    207

    Related Experiment Videos

    Last Updated: Jul 20, 2026

    Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
    09:49

    Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

    Published on: December 2, 2013

    10.3K
    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
    09:11

    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

    Published on: May 24, 2024

    415
    Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
    04:50

    Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

    Published on: January 17, 2025

    207

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Oncology Recapitulates Surgical Anatomy: Re-Defining Negative Oncologic Margins with R1 Vascular Hepatectomy in Colorectal Liver Metastases.

    Cancers·2026

    Hepaticojejunostomy to Treat Medically Refractory Bile Reflux After Esophagectomy With Gastric Pull-Up.

    The American surgeon·2026

    Robotic Whipple for Abnormal Pancreaticobiliary Junction With Recurrent Acute Pancreatitis: A Case Report.

    Cureus·2025

    Male or female sex stratified by age does not impact survival in patients with metastatic melanoma receiving immunotherapy.

    American journal of surgery·2025

    Impact of non-metropolitan residence on survival for gastric neuroendocrine tumors.

    American journal of surgery·2025

    Integrin CD103 expression in naive CD8+ T cells promotes cytokine-driven acquisition of memory phenotype and effector function.

    Immunity·2025

    Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer.

    Oncology (Williston Park, N.Y.)·2026

    Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City.

    Oncology (Williston Park, N.Y.)·2026

    Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance.

    Oncology (Williston Park, N.Y.)·2026

    Clinical Outcomes of Acute Pancreatitis in Patients With Multiple Myeloma.

    Oncology (Williston Park, N.Y.)·2026

    Primary Malignant Melanoma of the Colon: A Rare and Challenging Diagnosis.

    Oncology (Williston Park, N.Y.)·2026

    Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

    Oncology (Williston Park, N.Y.)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us